Evidence map›Paper›PMID 34173627›Full record

ArticleThe Lancet regional health. Europe2021

Myocardial Infarction incidence during national lockdown in two French provinces unevenly affected by COVID-19 outbreak: An observational study.

Eric Van Belle, Thibault Manigold, Adeline Piérache, Alain Furber, Nicolas Debry, Anne Luycx-Bore, Jean-Jacques Bauchart, Olivier Nugue, François Huchet, Mathieu Bic and 36 more

Open access · goldAbstract read
In one paragraph

Article in The Lancet regional health. Europe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. The hidden costs of national lockdowns.The Lancet regional health. Europe · 2021
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 20 institutions in 1 country.

Eric Van BelleCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Thibault ManigoldCHU Nantes, Nantes, France.
Adeline PiéracheDépartement de Biostatistiques, Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.
Alain FurberCardiologie, CHU Angers, France.
Nicolas DebryCH Saint-Philibert, Lille, France.
Anne Luycx-BoreCH Beauvais, Beauvais, France.
Jean-Jacques BauchartClinique la Louvière, Lille, France.
Olivier NugueCentre hospitalier Boulogne, France.
François HuchetCH Saint-Nazaire, France.
Mathieu BicCH Lens, France.
François VinchonCH Le Mans, France.
Smaïn SayahCH Creil, France.
Alexandre FournierCHU Amiens, France.
Eric DecoulxCH Roubaix, France.
Usman MouhammadCH Valenciennes, France.
Jérôme ClercCH Compiègne, France.
Aurélie ManchuelleClinique Bois Bernard, France.
Tahar LaziziCH Laval, France.
Akram ChmaitClinique Côte d'Opale, Saint-Martin Boulogne, France.
Julien JeannetteauClinique Saint-Joseph, Angers, France.
Pierre HénonCH Saint-Quentin, France, France.
Mickael BoninCHU Nantes, Nantes, France.
Marie Dupret-MinetCH Dunkerque, France, France.
Ashok TirouvanziamPolyclinique du Confluent, Nantes, France.
David MolcardCH Soissons, France.
Fabien ArabuckiCH La Roche Sur Yon, France.
Antoine PyClinique Victor Pauchet, Amiens, France.
Fabrice PrunierCardiologie, CHU Angers, France.
Cédric DelhayeCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Gilles LemesleCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Guillaume SchurtzCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Alessandro CosenzaCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Hugues SpillemaekerCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Basile VerdierCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Tom DenimalCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Thibault PamartCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Habib SyllaCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Dany JanahCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
David AouateCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Sina PorouchaniCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Valérie GuillezCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Guillaume BonnetHôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France.
Julien TernacleHôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France.
Julien LabreucheDépartement de Biostatistiques, Univ. Lille, CHU Lille, ULR 2694 - METRICS: évaluation des technologies de santé et des pratiques médicales, F-59000 Lille, France.
Guillaume CaylaCHU Nîmes, France.
Flavien VincentCHU Lille, Institut Cœur Poumon, Cardiology, Department of Interventional Cardiology for Coronary, Valves and Structural Heart Diseases, Inserm, U1011, Institut Pasteur de Lille, EGID, Université de Lille, Lille 59037, France.
Inserm · FRCentre Hospitalier Universitaire d'Angers · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre Hospitalier Universitaire de Nantes · FRUniversité de Lille · FRCentre Hospitalier Compiègne-Noyon · FRCentre Hospitalier de Beauvais · FRCentre Hospitalier de Lens · FRCentre Hospitalier Départemental Vendée · FRCentre Hospitalier de Roubaix · FRCentre Hospitalier de Saint-Quentin · FRCentre Hospitalier de Valenciennes · FRCentre Hospitalier du Mans · FRCentre Hospitalier Laennec · FRCentre Hospitalier Saint-Nazaire · FRCentre Hospitalier Universitaire Amiens-Picardie · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Nîmes · FRClinique Claude-Bernard · FRClinique Victor Hugo · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA reduction of admission for MI has been reported in most countries affected by COVID-19. No clear explanation has been provided.

methodsTo report the incidence of myocardial infarction (MI) admission during COVID-19 pandemic and in particular during national lockdown in two unequally affected French provinces (10-million inhabitants) with a different media strategy, and to describe the magnitude of MI incidence changes relative to the incidence of COVID-19-related deaths. A longitudinal study to collect all MIs from January 1 until May 17, 2020 (study period) and from the identical time period in 2019 (control period) was conducted in all centers with PCI-facilities in northern "Hauts-de-France" province and western "Pays-de-la-Loire" Province. The incidence of COVID-19 fatalities was also collected.

findingsIn "Hauts-de-France", during lockdown (March 18-May 10), 1500 COVID-19-related deaths were observed. A 23% decrease in MI-IR (IRR=0.77;95%CI:0.71-0.84,

interpretationIt highlights one of the potential collateral damages of COVID-19 outbreak on cardiovascular health with a dramatic reduction of MI incidence. It advocates for a careful and weighted communication strategy in pandemic crises.

fundingThe study was conducted without external funding.

Indexed as

Clinical outcomeCOVID-19, Coronavirus disease 2019COVID-19 outbreakMI, Myocardial InfarctionMortalityMyocardial InfarctionNSTEMI, non ST-segment elevation myocardial infarctionSTEMI, ST-segment elevation myocardial infarction

Identifiers

PMID34173627
PMCPMC7938895
OpenAlexW3120404225

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.